Zhongshan Hospital
Zhongshan Hospital
Shanghai, Shanghai Municipality, China7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-07-17 | NCT06796803 | |
| Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension | Digestive System Diseases, digestive system disorder, esophageal disorder, esophageal varices, liver disorder, portal hypertension | Recruiting | Not stated | 2025-05-14 | NCT06970509 | |
| Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled Air | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver | Recruiting | Not stated | 2025-05-13 | NCT06968234 | |
| Effectiveness of Treatments for Cirrhosis With Varicose Veins | Digestive System Diseases, liver disorder, portal hypertension | Active, not recruiting | Not stated | 2025-05-08 | NCT06961474 | |
| Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy | Digestive System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, digestive system disorder, gastroparesis, palsy, stomach disorder | Recruiting | Not applicable | 2025-01-22 | NCT06322680 | |
| Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 2 | 2025-01-22 | NCT05562297 | |
| Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 2 | 2023-12-12 | NCT06166589 |